CD8A and colorectal carcinoma: Our study demonstrated that the immunoscore, an immunohistochemistry‐based assessment of CD3+ and CD8+ T‐lymphocyte density, significantly correlated with OS and DFS, suggesting that immunoscore may be new prognostic and predictive marker for CRC.